When converting an insulin pump from U100 (100 units/mL) to U200 (200 units/mL) insulin, should the basal rate be halved and the insulin‑sensitivity factor (correction factor) and insulin‑to‑carbohydrate ratio be doubled?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

The statement is INCORRECT for insulin pump therapy.

When converting from U100 to U200 insulin in a pump, NO dose adjustments are needed—the pump settings remain identical because U200 formulations are bioequivalent to U100 on a unit-per-unit basis.

Why This Matters

The confusion likely stems from mixing up concentration with dosing. Here's the critical distinction:

For Bioequivalent Concentrated Insulins (U200 degludec, U200 lispro):

  • Basal rates: Keep the same unit/hour settings 1, 2
  • Correction factors (insulin sensitivity factor): Keep the same units per mg/dL
  • Carbohydrate ratios: Keep the same units per gram of carbohydrate
  • All pump parameters stay identical 3

The U200 formulations of insulin degludec and insulin lispro have pharmacokinetics similar to their U100 counterparts 1. A bioequivalence study demonstrated that U200 and U100 degludec can be used interchangeably with the 90% confidence intervals for AUC and Cmax falling within 0.80-1.25 3. This means 20 units of U200 delivers the same insulin effect as 20 units of U100—you're just injecting half the volume.

The Only Change Required:

  • Volume delivered decreases by 50% (because the insulin is twice as concentrated)
  • The pump automatically handles this when you load U200 insulin and program it correctly
  • Some pumps require you to specify the insulin concentration in settings

Common Pitfall to Avoid

Do NOT confuse this with U300 glargine or U500 regular insulin, which have different pharmacokinetic properties and may require dose adjustments 1, 2. U300 glargine has modestly lower efficacy per unit administered and longer duration of action 2. U500 regular insulin has completely different characteristics with delayed onset and prolonged duration 1.

For Non-Bioequivalent Concentrated Insulins:

  • U300 glargine: May need slight dose increases (typically 10-18% more units) 4
  • U500 regular insulin: Requires specialized pumps and different dosing strategies 5

Practical Implementation

When switching to U200 in a pump:

  1. Verify your pump is compatible with U200 insulin
  2. Update pump settings to indicate U200 concentration (if required by your pump model)
  3. Keep all dosing parameters unchanged: same basal rates, same carb ratios, same correction factors
  4. The pump will deliver half the volume to achieve the same unit dose
  5. Monitor glucose closely for the first few days as with any insulin change

The concentrated formulations exist primarily to reduce injection volume for patients requiring large insulin doses, improving comfort and adherence 6, 1. They are available only in prefilled pens (except U500) to minimize dosing errors 1, 2.

Related Questions

What should the dinner dose of U‑500 insulin (human regular insulin) be for a 123‑kg patient?
What factors could cause a false fasting insulin result?
For a 61-year-old female with type 1 diabetes, weight 79 kg, impaired renal function, overnight blood glucose 115‑124‑113 mg/dL, currently on insulin glargine (Lantus) 13 U daily, insulin‑to‑carbohydrate ratio 1 U per 10 g carbohydrate, and a medium correction factor, who is eating little and will undergo continuous renal replacement therapy (CRRT) today, how should the basal insulin dose, insulin‑to‑carbohydrate ratio, and insulin sensitivity factor be adjusted?
What is the interpretation and recommended management for a patient with a 2‑hour oral glucose tolerance test showing fasting glucose 108 mg/dL and 2‑hour glucose 191 mg/dL?
What is the initial step in diagnosing diabetes mellitus?
What prophylactic regimen is recommended for an elderly woman with recurrent urinary tract infections, taking into account renal function and potential contraindications?
Can you explain the histological appearance of pyknosis, karyorrhexis, and karyolysis and provide representative images?
Can benzodiazepines worsen depression in an adult patient with a history of depression?
What is the recommended glucagon dose and route for an adult with a food bolus obstruction when immediate endoscopy is unavailable?
Should I administer immediate (stat) doses of albendazole and tinidazole?
In a female radical cystectomy performed via an endopelvic approach, how should the endopelvic fascia be divided and subsequently repaired?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.